Kristian Wachtell Selected Research

Simvastatin (Zocor)

1/2022	Association of Annual N-Terminal Pro-Brain Natriuretic Peptide Measurements With Clinical Events in Patients With Asymptomatic Nonsevere Aortic Stenosis: A Post Hoc Substudy of the SEAS Trial.
1/2021	Frequency and Impact of Hyponatremia on All-Cause Mortality in Patients With Aortic Stenosis.
11/2020	Sudden cardiac death in asymptomatic patients with aortic stenosis.
12/2019	Relation of Lipid-Lowering Therapy to Need for Aortic Valve Replacement in Patients With Asymptomatic Mild to Moderate Aortic Stenosis.
1/2018	Effect Modifications of Lipid-Lowering Therapy on Progression of Aortic Stenosis (from the Simvastatin and Ezetimibe in Aortic Stenosis [SEAS] Study).
1/2018	Effect of simvastatin and ezetimibe on suPAR levels and outcomes.
1/2018	SuPAR predicts postoperative complications and mortality in patients with asymptomatic aortic stenosis.
11/2017	Antihypertensive Treatment With β-Blockade in Patients With Asymptomatic Aortic Stenosis and Association With Cardiovascular Events.
12/2016	SuPAR Predicts Cardiovascular Events and Mortality in Patients With Asymptomatic Aortic Stenosis.
8/2016	Assessing Optimal Blood Pressure in Patients With Asymptomatic Aortic Valve Stenosis: The Simvastatin Ezetimibe in Aortic Stenosis Study (SEAS).

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kristian Wachtell Research Topics

Disease

87	Hypertension (High Blood Pressure) 03/2022 - 02/2002
48	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 10/2020 - 02/2002
43	Aortic Valve Stenosis (Aortic Stenosis) 01/2022 - 04/2007
31	Stroke (Strokes) 12/2015 - 08/2004
31	Hypertrophy 08/2014 - 01/2002
28	Myocardial Infarction 01/2017 - 01/2003
27	Atrial Fibrillation 10/2020 - 08/2003
16	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 03/2004
12	Heart Failure 01/2021 - 02/2002
11	Albuminuria 12/2008 - 02/2002
7	Essential Hypertension 01/2019 - 09/2004
6	Cardiac Sudden Death (Sudden Cardiac Arrest) 11/2020 - 08/2003
5	Inflammation (Inflammations) 06/2016 - 04/2006
5	Diabetes Mellitus 04/2015 - 02/2002
4	Coronary Disease (Coronary Heart Disease) 01/2019 - 01/2003
4	ST Elevation Myocardial Infarction 01/2016 - 09/2007
4	Atherosclerosis 01/2014 - 11/2005
4	Atherosclerotic Plaque (Atheroma) 03/2012 - 04/2006
3	Isolated Systolic Hypertension 10/2019 - 02/2002
3	Myocardial Ischemia (Ischemic Heart Diseases) 07/2015 - 04/2013
3	Overweight 01/2015 - 07/2014
2	Coronary Artery Disease (Coronary Atherosclerosis) 12/2022 - 01/2017
2	Thrombosis (Thrombus) 01/2016 - 03/2014
2	Insulin Resistance 01/2015 - 04/2005
2	Fibrosis (Cirrhosis) 01/2014 - 08/2007
2	Pathologic Constriction (Stenosis) 03/2011 - 09/2008
2	Bundle-Branch Block (Fascicular Block) 06/2008 - 07/2007
2	Sclerosis 11/2005 - 10/2004
1	Hyponatremia 01/2021
1	Shock 01/2019
1	Cataract (Cataracts) 12/2015
1	Aortic Valve Disease 04/2015
1	Obesity 01/2015
1	Left Ventricular Dysfunction 12/2014
1	Weight Loss (Weight Reduction) 11/2014
1	Body Weight (Weight, Body) 11/2014
1	Weight Gain 11/2014
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 07/2014
1	Cardiogenic Shock 03/2014

Drug/Important Bio-Agent (IBA)

80	Losartan (Cozaar)FDA LinkGeneric 03/2022 - 02/2002
50	Atenolol (Tenormin)FDA LinkGeneric 06/2017 - 02/2002
41	Simvastatin (Zocor)FDA LinkGeneric 01/2022 - 04/2007
40	Ezetimibe (Zetia)FDA Link 01/2022 - 04/2007
38	Antihypertensive Agents (Antihypertensives)IBA 10/2019 - 02/2002
25	CreatinineIBA 12/2015 - 02/2002
22	AlbuminsIBA 12/2015 - 02/2002
17	LipidsIBA 12/2019 - 10/2005
11	HDL CholesterolIBA 10/2020 - 01/2003
10	pro-brain natriuretic peptide (1-76)IBA 12/2022 - 03/2004
9	C-Reactive ProteinIBA 06/2016 - 04/2006
7	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 03/2004
7	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 04/2005
6	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2015 - 08/2008
6	CholesterolIBA 12/2015 - 01/2003
5	Angiotensin Receptor AntagonistsIBA 01/2021 - 01/2005
5	Hypoglycemic Agents (Hypoglycemics)IBA 11/2014 - 10/2005
4	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2021 - 03/2005
4	Urokinase Plasminogen Activator ReceptorsIBA 01/2018 - 01/2014
4	Hemoglobins (Hemoglobin)IBA 03/2014 - 05/2006
3	LDL Lipoproteins (beta Lipoproteins)IBA 12/2019 - 12/2015
3	LDL CholesterolIBA 01/2018 - 06/2010
3	Biomarkers (Surrogate Marker)IBA 10/2015 - 01/2014
3	Digoxin (Digitek)FDA LinkGeneric 07/2015 - 08/2011
2	SodiumIBA 01/2021 - 01/2021
2	Spironolactone (Aldactone)FDA LinkGeneric 01/2021 - 01/2020
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 09/2006
2	oxidized low density lipoproteinIBA 12/2019 - 04/2015
2	Oxygen (Dioxygen)IBA 11/2015 - 05/2006
2	AdiponectinIBA 01/2015 - 07/2014
2	Interleukin-6 (Interleukin 6)IBA 01/2015 - 07/2014
2	Natriuretic PeptidesIBA 01/2015 - 05/2005
2	LeptinIBA 01/2015 - 07/2014
2	AdipokinesIBA 01/2015 - 07/2014
2	Insulin (Novolin)FDA Link 11/2014 - 09/2002
2	Uric Acid (Urate)IBA 08/2011 - 08/2010
2	HDL LipoproteinsIBA 06/2010 - 04/2007
2	A 19IBA 12/2008 - 08/2007
2	Indicators and Reagents (Reagents)IBA 12/2008 - 06/2008
2	Angiotensin IIIBA 01/2005 - 09/2002
2	Nitroglycerin (Dynamite)FDA LinkGeneric 05/2002 - 01/2002
1	finerenoneIBA 01/2021
1	Neprilysin (Neutral Endopeptidase)IBA 01/2021
1	Mineralocorticoid Receptor AntagonistsIBA 01/2020
1	Irbesartan FDA LinkGeneric 01/2020
1	Valsartan (Vals)FDA Link 01/2020
1	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2020
1	candesartanIBA 01/2020
1	paragonIBA 01/2020
1	Perindopril FDA LinkGeneric 01/2020
1	Troponin T (Troponin T1)IBA 01/2019
1	CoagulantsIBA 01/2017
1	Prednisolone (Predate)FDA LinkGeneric 12/2015
1	Warfarin (Coumadin)FDA LinkGeneric 03/2014
1	Dabigatran FDA Link 03/2014

Therapy/Procedure

33	Therapeutics 01/2021 - 02/2002
6	Percutaneous Coronary Intervention 01/2016 - 09/2007
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 07/2014 - 09/2008
1	Drug Therapy (Chemotherapy) 01/2020
1	Aftercare (After-Treatment) 01/2016
1	Thrombolytic Therapy 03/2014